Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sedana Medical AB's interest expense for the
three
months ended in Jun. 2026 was kr 0.0 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr-5.1 Mil.
Sedana Medical AB (OSTO:SEDANA) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Sedana Medical AB's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as
GuruFocus does not calculate Sedana Medical AB's interest coverage with the available data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Sedana Medical AB Interest Expense Historical Data
* Premium members only.
The historical data trend for Sedana Medical AB's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-5.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sedana Medical AB (OSTO:SEDANA) has a Interest Expense of kr-5.1 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sedana Medical AB and its competitors.
Is Sedana Medical AB's Interest Expense too high?
Sedana Medical AB's current Interest Expense is kr-5.1 Mil. Overall, Sedana Medical AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Interest Expense compare to ABT and SYK?
Sedana Medical AB's Interest Expense of kr-5.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sedana Medical AB and its competitors. Sedana Medical AB's current Interest Expense is kr-5.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr16.82, compared to a current price of kr10.36 — trading 38.4% below its estimated fair value. The current Interest Expense is kr-5.1 Mil. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current Interest Expense is kr-5.1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of kr10.36 is trading 38.4% below its estimated GF Value™ of kr16.82.
GuruFocus considers Sedana Medical AB to be Significantly Undervalued.
Key valuation signals for OSTO:SEDANA:
Interest Expense: kr-5.1 Mil
GF Value™: kr16.82 vs. price of kr10.36 (38.4% below fair value)
No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for OSTO:SEDANA
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SEDANA has been successfully added to your 
